Epidemiologic trends in HIV-associated lymphomas.

Area of Science:

• Oncology
• Infectious Diseases
• Epidemiology

Background:

• HIV infection is a significant risk factor for developing non-Hodgkin lymphoma (NHL) and Hodgkin disease.
• The advent of highly active antiretroviral therapy (HAART) in 1996 has profoundly impacted HIV disease progression and survival.
• Changes in the HIV-infected population's demographics and the widespread use of HAART have led to shifts in HIV-associated lymphoma epidemiology.

Purpose of the Study:

• To analyze the evolving epidemiology of lymphomas in the context of HIV infection and HAART.
• To understand the current and long-term risks of lymphoma in individuals living with HIV.
• To highlight the continued importance of studying lymphoma incidence and causes in the HIV-positive population.

Main Methods:

• Review of epidemiological data on HIV-associated lymphomas.
• Analysis of lymphoma incidence trends before and after the introduction of HAART.
• Examination of changes in the composition of the HIV-infected population.

Main Results:

• HIV infection significantly increases the risk for NHL and, to a lesser extent, Hodgkin disease.
• HAART has been associated with reported reductions in lymphoma risk, particularly for NHL.
• Long-term lymphoma risks in the HAART era remain under investigation, and the epidemiology continues to evolve.

Conclusions:

• Lymphomas represent a major and often fatal comorbidity in individuals with HIV.
• The epidemiology of HIV-associated lymphomas has changed since the introduction of HAART.
• Continued research into the incidence and etiology of these cancers is crucial for patient outcomes.